GGrantIndex
Sort

130,381 grants matching hiv

Efficacy of Oral CMV/SIV Vectors

$817,129
Louis J. Picker · Oregon Health & Science University · R01 · FY2011 · DE

Evaluation of HIV-associated Cardiac Dysfunction in Women

$817,073
Jorge R Kizer · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · HL

Stabilization of the RNA Complement of Enveloped Viruses: Beta Testing and Manufacturing Scale-up of a Novel Filter Paper Product for the Field Collection of Dried Blood Spots

$817,026
Shanavaz Nasarabadi · Gentegra, Llc · R44 · FY2019 · AI

Antibody Responses in Aging SIV Infected Monkeys

$817,006
Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2017 · AI

FIU-Diversity Center for Genomic Research (FIU-DCGR)

$816,988
Xuexia Wang · Florida International University · UG3 · FY2024 · HG

Cost-Effectiveness of Preventing HIV Complications

$816,972
Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2024 · AI

Development of a Sustained Release Injectable Formulation for Long-Term Delivery of ELQs

$816,964
Michael Kevin Riscoe · Oregon Health & Science University · R01 · FY2020 · AI

High-parametric flow cytometry cell sorter for human immunology studies.

$816,944
Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · S10 · FY2023 · OD

Multi-omics characterization of HIV-associated changes in the gut microbiome and host mucosal immunity

$816,908
Douglas Kwon · Massachusetts General Hospital · R01 · FY2018 · DK

Office of the Clinical Director Clinical Services Research

$816,887
Maryland Pao · National Institute Of Mental Health · ZIA · FY2020 · MH

Fluorescent nanofoldamers for multiplex flow cytometry

$816,870
Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2023 · GM

AIDS International Training and Research Program

$816,784
Carey Farquhar · University Of Washington · D43 · FY2008 · TW

Clinical Studies of Interactions Between HIV and Malaria

$816,761
Diane V Havlir · University Of California, San Francisco · U01 · FY2008 · AI

Center for Metabolic Research on HIV and Drug Use

$816,761
Sherwood L Gorbach · Tufts University Boston · P30 · FY2011 · DA

PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE

$816,746
Nancy Logan Haigwood · Oregon Health & Science University · R01 · FY2017 · AI

Pharmacogenomics of HIV Therapy

$816,720
David W Haas · Vanderbilt University Medical Center · R01 · FY2023 · AI

Epitope-focused vaccine strategies against Zika virus

$816,691
Michel C Nussenzweig · Rockefeller University · P01 · FY2020 · AI

Leveraging membrane Env liposome vaccine design to elicit multi-target cross-neutralization of HIV

$816,634
Michael B Zwick · Scripps Research Institute, The · R01 · FY2024 · AI

Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV disease

$816,613
Sulggi Angela Lee · University Of California, San Francisco · R01 · FY2019 · AI

Stanford AIDS Clinical Trials Unit

$816,602
Andrew Zolopa · Stanford University · U01 · FY2008 · AI

Optimizing HIV Care in Less Developed Countries

$816,590
Kenneth Alan Freedberg · Massachusetts General Hospital · R37 · FY2019 · AI

Increasing engagement and improving HIV care outcomes via stigma reduction in an online social networking intervention among racially diverse young men who have sex with men and transgender women

$816,583
Jose Arturo Bauermeister · University Of Pennsylvania · R01 · FY2018 · MD

SOUTHEAST PEDIATRIC AIDS CLINICAL TRIALS UNIT

$816,559
University Of Alabama At Birmingham · U01 · FY2000 · AI

Targeting Brain Macrophage Reservoirs of SIV during HAART

$816,550
Woong-Ki Kim · Eastern Virginia Medical School · R01 · FY2017 · MH

Video DOT and Economic Incentives to promote adherence to LTBI therapy

$816,546
Maunank Shah · Johns Hopkins University · R01 · FY2022 · AI